Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193805-25-001239
Filing Date
2025-08-27
Accepted
2025-08-27 16:06:06
Documents
15
Effectiveness Date
2025-08-27

Document Format Files

Seq Description Document Type Size
1 e664796_s8-immunic.htm S-8 65330
2 e664796_ex5-1.htm EX-5.1 13898
3 e664796_ex23-1.htm EX-23.1 1638
4 e664796_ex107.htm   iXBRL EX-FILING FEES 13922
5 GRAPHIC image1.jpg GRAPHIC 8861
  Complete submission text file 0001193805-25-001239.txt   229139

Data Files

Seq Description Document Type Size
18 EXTRACTED XBRL INSTANCE DOCUMENT e664796_ex107_htm.xml XML 4974
Mailing Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036
Business Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036 (332) 255-9818
IMMUNIC, INC. (Filer) CIK: 0001280776 (see all company filings)

EIN.: 562358443 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-289884 | Film No.: 251265245
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)